Vishal Bhavsar reviews an EU study of nearly 3,000 people across 6 EU countries, looking at the treated incidence of schizophrenia and psychotic disorders. It helps us better understand who gets psychosis, when, and where.
[read the full story...]
Suzi Gage summarises a recent GWAS of lifetime cannabis use, which reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. Interesting new evidence ahead of our Mental Health Question Time #MHQT event in London tomorrow.
[read the full story...]
Simon Bradstreet is left feeling frustrated by this systematic review of person-oriented recovery in people living with severe mental illness, which neglected to include a significant amount of relevant research.
[read the full story...]
Elwira Lubos summarises the recent ATLAS RCT of antipsychotic treatment for very late-onset schizophrenia-like psychosis, which provides evidence for the effectiveness of a very low dose of Amisulpride (100 mg).
[read the full story...]
Joanne Wallace summarises a systematic review that highlights disparities in the management of cardiovascular risk factors in people with mental illness.
[read the full story...]
Rudiger Pittrof and Elana Covshoff from SHRINE (Sexual and Reproductive Health Rights, Inclusion and Empowerment) explore a recent review, which looks at the impact of severe mental disorders and psychotropic medications on sexual health and its implications for clinical management.
[read the full story...]
Vishal Bhavsar explores a recent study that uses data linkage to electronic patient records to assess the validity of selected mental health diagnoses in English Hospital Episode Statistics.
[read the full story...]
Laoise Renwick considers the findings of a recent systematic review on the safety of service users with severe mental illness receiving inpatient care on medical and surgical wards.
[read the full story...]
Marcus Munafo looks at a Chinese genome-wide association study that claims to have identified some of the genes associated with response to antipsychotic treatment.
[read the full story...]
Elwira Lubos summarises a recent review of reviews looking at the evidence for improving outcomes in first-episode psychosis.
[read the full story...]
